Pharmaceutical giant pulls plug on Aids vaccine trial

A promising experimental Aids vaccine failed to work in a large international test, leading the US-based developer to halt the study, it has been revealed.

Pharmaceutical giant Merck said it is ending enrolment and vaccination of volunteers in the study, which was partly funded by the National Institutes of Health in the US.